React Native Development for Medical Device Manufacturers

React Native development for medical device manufacturers is cross-platform mobile application delivery for iOS and Android from a single TypeScript codebase, built to meet FDA 21 CFR Part 11 and ISO 13485 requirements without doubling your engineering budget. QServices builds device companion apps, field service tools, and post-market surveillance dashboards for regulated manufacturers. Explore our React Native development services to see the full scope of what we deliver.

Why medical device manufacturers need a mobile app strategy right now

Medical device manufacturers face pressure from three directions at once. The FDA's December 2023 cybersecurity guidance now requires every premarket submission involving software to include a Software Bill of Materials (SBOM), documented architecture, and evidence of security testing. Manufacturers who built companion apps as web wrappers five years ago are scrambling to meet these requirements before their next 510(k) or PMA cycle.

The EU MDR transition deadline for legacy Class IIa and IIb devices runs to May 2026. Manufacturers with CE-marked devices running companion apps in European markets must ensure those apps satisfy Article 61 clinical evaluation requirements. That deadline is close, and retrofitting a non-compliant app costs far more than building it right the first time.

Post-market surveillance has shifted from paper complaint logs to real-time mobile data collection. The ISO 13485:2016 standard requires documented procedures for gathering post-market feedback, and a well-built mobile app is now the fastest way to satisfy that requirement while feeding clean, structured data into your QMS. Our regulated-industry solutions address these compliance pressures directly, not generically.

What we build for medical device manufacturers

Our React Native work for this sector covers five recurring deliverables, each designed around the validation and documentation overhead that defines regulated medical software:

• Device companion apps: iOS and Android from one codebase, with Bluetooth or USB connectivity to hardware. A single codebase cuts initial build cost by 30-40% compared to native development. QServices Human-in-the-Loop (HITL) governance means your clinical lead approves every over-the-air update before it reaches users.
• Post-market surveillance dashboards: Mobile tools for field reps and patients to report adverse events and product feedback directly into your QMS (MasterControl or Veeva Vault). A quality engineer reviews flagged reports via our HITL workflow before they are escalated to regulatory.
• Field service apps: Calibration checklists, installation verification, and service history capture for field technicians. Replaces paper forms and integrates with SAP or Oracle EBS for work order management. Supervisors approve out-of-spec results via HITL before the service record closes.
• Clinical trial companion apps: Patient-facing apps for e-PRO data collection and medication reminders, built for 21 CFR Part 11 audit trail requirements. Site investigators review patient-entered data via HITL before it is locked in the clinical database.
• Regulatory submission tools: Internal apps for quality teams to manage 510(k) document packages, track submission milestones, and coordinate cross-functional sign-offs. Cuts the administrative overhead that makes regulatory submissions take months.

How a React Native engagement actually works

A typical React Native project for a medical device manufacturer runs 10-28 weeks depending on complexity. Here is how the engagement unfolds, phase by phase:

1. Discovery and requirements (Weeks 1-2): We interview your VP of Quality, Head of Regulatory, and IT Director. We document regulatory constraints (21 CFR Part 11, ISO 13485, EU MDR), map integrations to SAP, Oracle EBS, Veeva Vault, or MasterControl, and agree on the validation approach upfront. HITL checkpoint: the requirements document is reviewed and signed by your quality team before any code is written.
2. Architecture and design (Weeks 2-4): We select the React Native, Expo, TypeScript, and Redux Toolkit stack. We produce wireframes that follow platform-specific UX conventions, not a web layout forced onto a phone. HITL checkpoint: your clinical or quality lead reviews all UX flows before build begins.
3. Sprint development (Weeks 4-16): Two-week sprints with your quality team in each demo. We write Installation Qualification (IQ) and Operational Qualification (OQ) documentation as we build, not retroactively. Fastlane automates builds and TestFlight or Play Store distribution for UAT.
4. Validation and testing (Weeks 14-22): User Acceptance Testing runs against the IQ/OQ/PQ protocol. We support your team through Performance Qualification. HITL checkpoint: no code merges to the release branch without a documented review pass.
5. App Store submission (Weeks 22-26): We prepare App Store and Play Store submissions, including privacy nutrition labels, health app entitlements, and MDM configuration profiles for enterprise distribution. Budget 2-4 weeks for review cycles. Apple routinely requests additional documentation for health and medical apps, and this timeline cannot be compressed.
6. Hypercare and handoff (Weeks 26-28): Two weeks of post-launch support, then a full handoff of source code, documentation, and the Fastlane CI/CD pipeline to your engineering team.

What this costs

A React Native project for a medical device manufacturer typically runs between $50,000 and $300,000, reflecting both build scope and the compliance overhead that comes with regulated software. Our standard rate is $35/hour; senior architects and validation specialists bill at $65/hour. See our full React Native development cost guide for a detailed breakdown by app type and complexity.

Drives cost up:

• 21 CFR Part 11 validation protocols: IQ/OQ/PQ documentation adds 15-25% to project cost
• Bluetooth or USB device hardware integration
• Integration with Veeva Vault, MasterControl, SAP, or Oracle EBS (add $3,000-$12,000 per system)
• Third-party compliance review required by your quality team (add $5,000-$20,000)
• Clinical trial or e-PRO functionality requiring FDA review

Keeps cost down:

• Single React Native codebase for iOS and Android saves 30-40% versus building native twice
• Existing design system or established brand guidelines
• Clear, frozen requirements before development starts
• Using Expo managed workflow for standard device APIs

Three things medical device buyers usually get wrong

1. Treating the companion app as separate from the regulated device. If your app controls, monitors, or affects the functionality of a medical device, the FDA classifies it as Software as a Medical Device (SaMD) under 21 CFR. We have seen buyers start a companion app project without involving their regulatory team, then spend six months retrofitting validation evidence that should have been built from day one. Put your Head of Regulatory in the kickoff meeting, not the review meeting.

2. Underestimating App Store review timelines for health apps. Apple's App Store review for apps in the health and medical category takes 2-4 weeks on first submission, not the 24-48 hours developers expect for standard consumer apps. Apple will request a letter of medical authorization for regulated device apps. Google Play has parallel requirements. We have seen manufacturers delay a device launch by eight weeks because nobody put App Store submission on the project schedule. Treat it as a project milestone with its own date.

3. Skipping platform-specific UX work and shipping a web layout on mobile. Medical device companion apps are used in clinical environments with gloved hands, under bright procedure lighting, often under time pressure. A UI designed for a 1440px desktop monitor does not work on a phone in an operating room. React Native provides native components, but you still have to design for the platform. Apps that skip a dedicated platform UX sprint get flagged in usability testing and require a full redesign cycle. That costs more than doing the UX work upfront.

Recent work with healthcare and regulated-industry clients

Our most closely related case study is our work with Equalution, a personalized nutrition platform that required a dual-app architecture: a React Native patient-facing app and a React.js dietician web portal. The patient app delivered ML-driven personalized calorie and macro targets based on body metrics. The project required careful UX design to make complex health data usable on a mobile screen, the same challenge companion apps for medical devices face daily.

We have also built mobile platforms with strict audit-trail controls and two-factor authentication, including the My Delivery logistics platform with real-time proof-of-delivery and Zoho-powered invoicing. While neither is a medical device project, both reflect our approach to mobile software where data integrity and accountability are non-negotiable requirements, not afterthoughts.

How long does React Native development take for a medical device manufacturer?

A React Native project for a medical device manufacturer takes 10-28 weeks from kickoff to App Store launch. Simple companion apps with no hardware integration land at 10-14 weeks. Apps requiring 21 CFR Part 11 validation protocols, multi-system integrations, and FDA submission support run 22-28 weeks. App Store review for health and medical apps adds another 2-4 weeks on top of development. Our team at QServices writes validation documentation in parallel with development, sprint by sprint, which keeps the overall timeline as short as the compliance process allows.